Development of two ELISA for estrogen and progesterone receptor with sufficient sensitivity for fine needle aspirate and core biopsy

Journal of Clinical Laboratory Analysis

Volumn 15, Issue 3, 2001, Pages 138-143

  Sun, C F ^a   Wu, T L ^a   Tsao, K C ^b   Wu, J T ^a,c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^c ARUP LABORATORIES   (United States)

Author keywords

Breast tumor cytosol; ELISA; Estrogen receptor; Fine needle aspiration biopsy; Progesterone receptor

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; RECEPTOR ANTIBODY;

ANTIBODY AFFINITY; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; NEEDLE BIOPSY; PROGNOSIS; SENSITIVITY AND SENSIBILITY;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BIOPSY; BIOPSY, NEEDLE; BREAST NEOPLASMS; CALIBRATION; CYTOSOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOASSAY; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SENSITIVITY AND SPECIFICITY;

EID: 0035010745     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcla.1017     Document Type: Article

References (5)

1. The value of estrogen and progesterone receptors in the treatment of breast cancer
2. Steroid hormone receptor in breast cancer
3. Diagnosis of palpable breast lesions in younger women by the modified triple test is accurate and cost-effective
4. c-erbB-2 and steroid receptors in carcinoma cells obtained by fine-needle aspiration from primary breast carcinomas during tamoxifen treatment
5. Effect of different designs of immunoassays on "hook effect" of CA 19-9 measurement